文献速递炎症性肠病

克罗恩病的微生物特征

A microbial signature for Crohn's disease.
PubMed 文献 · Gut · 2017-02-07

研究对比了来自四个国家的2045份非IBD和IBD粪便样本,采用16S rRNA测序分析。在西班牙队列中,克罗恩病患者的菌群失调显著大于溃疡性结肠炎患者,并提出了一个由八个微生物群组成的克罗恩病特异性微生物特征。该特征在全队列中检测克罗恩病 vs 健康对照、厌食症、肠易激综合征和溃疡性结肠炎的灵敏度为80%,特异度分别为94%、94%、89%和91%。

要点

  • 克罗恩病患者菌群失调显著大于溃疡性结肠炎患者,表现为多样性降低和菌群稳定性下降。
  • 提出了由八个微生物群组成的克罗恩病特异性微生物特征。
  • 该特征区分克罗恩病与非克罗恩病的总体灵敏度为80%,特异度为89%–94%。

核心结论

  • 溃疡性结肠炎和克罗恩病在微生物组水平上是炎症性肠病的两个不同亚型。
  • 首次提出不依赖地理区域的微生物标志物以区分克罗恩病与非克罗恩病。

研究设计与样本

  • 纵向研究分析来自四个国家(西班牙、比利时、英国和德国)的2045份非IBD和IBD粪便样本。

主要发现

  • 在西班牙队列中,克罗恩病患者的菌群失调显著大于溃疡性结肠炎患者,表现为多样性更降低和微生物群落更不稳定。
  • 提出八个微生物群作为克罗恩病的特异性微生物特征。
  • 该特征在全队列中检测克罗恩病 vs 健康对照的灵敏度为80%、特异度为94%。
  • 检测克罗恩病 vs 厌食症的灵敏度为80%、特异度为94%。
  • 检测克罗恩病 vs 肠易激综合征的灵敏度为80%、特异度为89%; vs 溃疡性结肠炎的灵敏度为80%、特异度为91%。

关键数值与推荐

  • 克罗恩病特异性微生物特征由八个微生物群组成。
  • 该特征检测克罗恩病 vs 健康对照、厌食症、肠易激综合征和溃疡性结肠炎的总体灵敏度为80%,特异度分别为94%、94%、89%和91%。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: A decade of microbiome studies has linked IBD to an alteration in the gut microbial community of genetically predisposed subjects. However, existing profiles of gut microbiome dysbiosis in adult IBD patients are inconsistent among published studies, and did not allow the identification of microbial signatures for CD and UC. Here, we aimed to compare the faecal microbiome of CD with patients having UC and with non-IBD subjects in a longitudinal study. DESIGN: We analysed a cohort of 2045 non-IBD and IBD faecal samples from four countries (Spain, Belgium, the UK and Germany), applied a 16S rRNA sequencing approach and analysed a total dataset of 115 million sequences. RESULTS: In the Spanish cohort, dysbiosis was found significantly greater in patients with CD than with UC, as shown by a more reduced diversity, a less stable microbial community and eight microbial groups were proposed as a specific microbial signature for CD. Tested against the whole cohort, the signature achieved an overall sensitivity of 80% and a specificity of 94%, 94%, 89% and 91% for the detection of CD versus healthy controls, patients with anorexia, IBS and UC, respectively. CONCLUSIONS: Although UC and CD share many epidemiologic, immunologic, therapeutic and clinical features, our results showed that they are two distinct subtypes of IBD at the microbiome level. For the first time, we are proposing microbiomarkers to discriminate between CD and non-CD independently of geographical regions.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Pascal V, Pozuelo M, Borruel N, et al. A microbial signature for Crohn's disease. Gut. 2017. PMID: 28179361. doi:10.1136/gutjnl-2016-313235

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。